RT Journal Article SR Electronic T1 Mechanism-Based Inactivation of Cytochrome P450 3A4 by 17α-Ethynylestradiol: Evidence for Heme Destruction and Covalent Binding to Protein JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 160 OP 167 DO 10.1124/jpet.301.1.160 VO 301 IS 1 A1 Lin, Hsia-lien A1 Kent, Ute M. A1 Hollenberg, Paul F. YR 2002 UL http://jpet.aspetjournals.org/content/301/1/160.abstract AB 17α-Ethynylestradiol (EE), a major constituent of many oral contraceptives, inactivated the testosterone 6β-hydroxylation activity of purified P450 3A4 reconstituted with phospholipid and NADPH-cytochrome P450 reductase in a mechanism-based manner. The inactivation of P450 3A4 followed pseudo first order kinetics and was dependent on NADPH. The values for the KIand kinact were 18 μM and 0.04 min−1, respectively, and thet1/2 was 16 min. Incubation of 50 μM EE with P450 3A4 at 37°C for 30 min resulted in a 67% loss of testosterone 6β-hydroxylation activity accompanied by a 35% loss of the spectral absorbance of the native protein at 415 nm and a 70% loss of the spectrally detectable P450-CO complex. The inactivation of P450 3A4 by EE was irreversible. Testosterone, an alternate substrate, was able to protect P450 3A4 from EE-dependent inactivation. The partition ratio was ∼50. The stoichiometry of binding was approximately 1.3 nmol of an EE metabolite bound per nmol of P450 3A4 inactivated. SDS-polyacrylamide gel electrophoresis analysis demonstrated that [3H]EE was irreversibly bound to the P450 3A4 apoprotein. After extensive dialysis of the [3H]EE inactivated samples, high-pressure liquid chromatography (HPLC) analysis demonstrated that the inactivation resulting from EE metabolism led to the destruction of approximately half the heme with the concomitant generation of modified heme and EE-labeled heme fragments and produced covalently radiolabeled P450 3A4 apoprotein. Electrospray mass spectrometry demonstrated that the fraction corresponding to the major radiolabeled product of EE metabolism has a mass (M − H)− of 479 Da. HPLC and gas chromatography-mass spectometry analyses revealed that EE metabolism by P450 3A4 generated one major metabolite, 2-hydroxyethynylestradiol, and at least three additional metabolites. In conclusion, our results demonstrate that EE is an effective mechanism-based inactivator of P450 3A4 and that the mechanism of inactivation involves not only heme destruction, but also the irreversible modification of the apoprotein at the active site. The American Society for Pharmacology and Experimental Therapeutics